Photos

251208-N-ND850-1004

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), examines the method by which research scientists at Naval Medical Research Unit (NAMRU) San Antonio assess a wide range of inflammatory biomarkers in biological samples in support of DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program at the Battlefield Health & Trauma Research Institute. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)